Elizabeth Folkerd
- Endocrinology, Diabetes and Metabolism top 0.5%
- Genetics top 1%
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Molecular Biology top 10%
- Co-authors
- Mitch DowsettRobert LubenKay‐Tee KhawNicholas J. WarehamSheila BinghamAilsa WelchAlison ReidJohann S. de Bono
- Topics
- Estrogen and related hormone effects (51 papers)Cancer Risks and Factors (21 papers)Hormonal and reproductive studies (16 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Elizabeth Folkerd
88 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 1.9k
- Genetics 1.7k
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.4k
- Molecular Biology 1.0k
Countries citing papers authored by Elizabeth Folkerd
This map shows the geographic impact of Elizabeth Folkerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Folkerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Folkerd more than expected).
Fields of papers citing papers by Elizabeth Folkerd
This network shows the impact of papers produced by Elizabeth Folkerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Folkerd. The network helps show where Elizabeth Folkerd may publish in the future.
Co-authorship network of co-authors of Elizabeth Folkerd
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Folkerd. A scholar is included among the top collaborators of Elizabeth Folkerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Folkerd. Elizabeth Folkerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 99 | |
| 2 | 2 | |
| 3 | 54 | |
| 4 | 21 | |
| 5 | 66 | |
| 6 | 18 | |
| 7 | 54 | |
| 8 | Abiraterone acetate: the novel application of a CYP450c17 inhibitor to the treatment of both prostate and breast cancer | 1 |
| 9 | 12 | |
| 10 | 24 | |
| 11 | Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Drivenbreakdown → | 666 |
| 12 | Selective inhibition of CYP17 with abiraterone acetate is well tolerated and results in a high response rate in castration-resistant prostate cancer (CRPC) | 1 |
| 13 | 196 | |
| 14 | 43 | |
| 15 | 36 | |
| 16 | 82 | |
| 17 | 64 | |
| 18 | 62 | |
| 19 | 278 | |
| 20 | 11 |
About Elizabeth Folkerd
Elizabeth Folkerd is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Reproductive Medicine, having authored 90 papers that have together received 5.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (51 papers), Cancer Risks and Factors (21 papers) and Hormonal and reproductive studies (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Cancer Research (995 citations) and Genetics (1.7k citations). Elizabeth Folkerd has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Mitch Dowsett, Robert Luben, Kay‐Tee Khaw, Nicholas J. Wareham, Sheila Bingham, Ailsa Welch, Alison Reid, Johann S. de Bono, Gerhardt Attard and V.H.T. James. Their work appears in journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.